Cargando…
A Multi-Center Validated Subtyping Model of Esophageal Cancer Based on Three Metabolism-Related Genes
Metabolic reprogramming is a hallmark of malignancy. Understanding the characteristics of metabolic reprogramming in esophageal squamous cell carcinoma (ESCC) helps uncover novel targets for cancer progression. In this study, 880 metabolism-related genes were identified from microarray data and then...
Autores principales: | Liu, Yu, Wang, Liyu, Fang, Lingling, Liu, Hengchang, Tian, He, Zheng, Yujia, Fan, Tao, Li, Chunxiang, He, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573269/ https://www.ncbi.nlm.nih.gov/pubmed/34760709 http://dx.doi.org/10.3389/fonc.2021.772145 |
Ejemplares similares
-
The Prognostic Significance of Metabolic Syndrome and a Related Six-lncRNA Signature in Esophageal Squamous Cell Carcinoma
por: Liu, Yu, et al.
Publicado: (2020) -
Transmembrane Protein-Based Risk Model and H3K4me3 Modification Characteristics in Lung Adenocarcinoma
por: Fan, Tao, et al.
Publicado: (2022) -
Lipid metabolism–related lncRNA SLC25A21‐AS1 promotes the progression of oesophageal squamous cell carcinoma by regulating the NPM1/c‐Myc axis and SLC25A21 expression
por: Liu, Yu, et al.
Publicado: (2022) -
CXXC finger protein 1 (CFP1) bridges the reshaping of genomic H3K4me3 signature to the advancement of lung adenocarcinoma
por: Fan, Tao, et al.
Publicado: (2023) -
A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma
por: Zheng, Yujia, et al.
Publicado: (2021)